Randomized Trial of E-mail Follow-up Care After Cognitive Behavioural Treatment for Depression
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- Depressive Disorders
- Sponsor
- Universitätsklinikum Hamburg-Eppendorf
- Enrollment
- 92
- Locations
- 1
- Primary Endpoint
- Measure of the severity of depression - Beck Depression Inventory (BDI- II)
- Status
- Completed
- Last Updated
- 10 years ago
Overview
Brief Summary
The primary objective of this study is to test in a randomized effectiveness trial if e-mail delivered cognitive behavioural treatment is an effective follow-up care approach in the treatment of depression under clinically representative conditions.
Detailed Description
Depression belongs to the most prevalent mental disorders and often goes along with a high burden of disease. Although the efficacy and the effectiveness of psychological treatments for depressive disorders have been demonstrated, there remains the problem of maintaining the benefits achieved during the initial treatment phase. Therefore options of follow-up care have to be considered. Since access to psychotherapeutic treatments is limited and costly, internet-based interventions can offer a feasible opportunity for follow-up care in order to enhance the long-term effectiveness of psychotherapy.
Investigators
PD Dr. phil. Birgit Watzke
Principal Investigator
Universitätsklinikum Hamburg-Eppendorf
Eligibility Criteria
Inclusion Criteria
- •Depressive disorder: F32.0-F32.2; F33.0-F33.2; F34.1 according to ICD-10
- •Precursory CBT
- •Internet access
Exclusion Criteria
- •No knowledge of the German language
- •Risk of suicide
- •Acute psychosis or psychotic symptoms
- •Established concurrent in vivo CBT after discharge from inpatient CBT
Outcomes
Primary Outcomes
Measure of the severity of depression - Beck Depression Inventory (BDI- II)
Time Frame: Change in the BDI-II from baseline (beginning of treatment) to follow up (3 months after termination of the follow-up care)
Secondary Outcomes
- Depressive relapse/recurrence(Measured at follow up (3 months after termination of the follow-up care))
- Measure of health related quality of life - SF-8(Change in the SF-8 from baseline (beginning of treatment) to follow up (3 months after termination of the follow-up care)
- GAD-7(Change in the GAD-7 from baseline (beginning of treatment) to follow up (3 months after termination of the follow-up care))